Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04789018

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetics cases, precision treatment, and screening recommendation. Information gained from interviews and surveys of participants taking part in the virtual genetics board may lend insights into perceived usefulness, perceived ease of use, acceptability, self-efficacy, genetics knowledge, and barriers/facilitators to implementation to refine the process.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Prostate Carcinoma Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

About this study

PRIMARY OBJECTIVE:

I. To assess perceived usefulness of a virtual genetics board.

SECONDARY OBJECTIVE:

I. To assess acceptability/feasibility, perceived ease of use, self-efficacy for recommendations, genetics knowledge.

OUTLINE:

Participants complete a survey about genetic knowledge and self efficacy and then attend virtual genetics board. After virtual genetics board meeting, participants complete a second survey about perceived usefulness, ease of use, acceptability, feasibility, self-efficacy and genetic knowledge. Participants may also complete a semi-structured interview after virtual genetics board.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Individuals must meet one of the following inclusion criteria in order to be eligible to participate in the study:

  • Healthcare providers (medical oncologists, radiation oncologists, urologists, primary care providers, mid-level providers) who evaluate, manage, or treat men with prostate cancer or screen men for prostate cancer.
  • Providers who perform prostate cancer genetic testing for men (genetic counselors or healthcare providers)
  • Scientists and researchers
  • Advocacy or patient stakeholder organization members

Exclusion criteria

  • Non-medical providers

Treatment and study plan

Educational Intervention

Other

Attend virtual genetics board

Other names: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

Survey Administration

Other

Complete survey

interview

Other

Complete interview

Primary outcomes

  1. Mean Likert scaled perceived usefulness scores of the virtual genetics board

    Time frame: After virtual genetics board

    Perceived usefulness will be judged against a benchmark mean score of 5/7.

Secondary outcomes

  1. Means or changes in means of Likert scaled acceptability/feasibility

    Time frame: Before and after virtual genetics board

    Will be summarized by means, standard deviations, and 95% confidence intervals.

  2. Perceived ease of use

    Time frame: After virtual genetics board

    Will be summarized by means, standard deviations, and 95% confidence intervals.

  3. Self-efficacy for recommendations

    Time frame: Before and after virtual genetics board

    Will be summarized by means, standard deviations, and 95% confidence intervals.

  4. Change in mean scores on 17 genetics knowledge test questions

    Time frame: Baseline up to post-virtual genetics board

    Will be summarized by means, standard deviations, and 95% confidence intervals.

Sponsors and collaborators

Lead sponsor

Thomas Jefferson University

Other

Registry information

Official study title

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology ENGAGEMENT Study (Virtual Genetics Board)

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Mar 9, 2021
Registry last updated
Oct 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.